Showing results 1 to 8 of 8
Title | Author(s) | Issue Date | |
---|---|---|---|
A natural protein based platform for the delivery of Temozolomide acid to glioma cells Journal:European Journal of Pharmaceutics and Biopharmaceutics | 2021 | ||
2021 | |||
2023 | |||
Plasmid DNA ionisable lipid nanoparticles as non-inert carriers and potent immune activators for cancer immunotherapy Journal:Journal of Controlled Release | 2024 | ||
Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview Journal:Biomaterials Science | 2022 | ||
RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells Journal:Journal of Controlled Release | 2024 | ||
Spatiotemporal tracking of gold nanorods after intranasal administration for brain targeting Journal:Journal of Controlled Release | 2023 | ||
The interplay of solvent-drug-protein interactions during albumin nanoparticles formulations for temozolomide delivery to brain cancer cells Journal:Journal of Pharmacy and Pharmacology | 2023 |